SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437786-17-000020
Filing Date
2017-05-04
Accepted
2017-05-04 16:27:32
Documents
55
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q imdz331201710-q.htm 10-Q 842273
2 EXHIBIT 31.1 ex311imdz2017q1.htm EX-31.1 8010
3 EXHIBIT 31.2 ex312imdz2017q1.htm EX-31.2 8112
4 EXHIBIT 32.1 ex321imdz2017q1.htm EX-32.1 4865
5 EXHIBIT 32.2 ex322imdz2017q1.htm EX-32.2 5117
  Complete submission text file 0001437786-17-000020.txt   4035873

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imdz-20170331.xml EX-101.INS 677798
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imdz-20170331.xsd EX-101.SCH 34579
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imdz-20170331_cal.xml EX-101.CAL 54359
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imdz-20170331_def.xml EX-101.DEF 155067
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imdz-20170331_lab.xml EX-101.LAB 485879
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imdz-20170331_pre.xml EX-101.PRE 273669
Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Filer) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36561 | Film No.: 17814352
SIC: 2834 Pharmaceutical Preparations